Defence Therapeutics Inc.
DTCFF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,080 | $131 | $131 | $57 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $88 | $46 | $33 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $17 | $33 | $61 |
| Total Curr. Assets | $2,172 | $193 | $197 | $214 |
| Property Plant & Equip (Net) | $192 | $210 | $227 | $264 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $192 | $210 | $227 | $264 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,364 | $403 | $425 | $478 |
| Liabilities | – | – | – | – |
| Payables | $1,153 | $2,247 | $2,185 | $2,091 |
| Short-Term Debt | $1,393 | $1,284 | $1,842 | $1,739 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $38 | $325 | $519 | $225 |
| Total Curr. Liab. | $2,583 | $3,857 | $4,546 | $4,054 |
| LT Debt | $0 | $0 | $0 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $23 | $29 | $36 |
| Total Liabilities | $2,583 | $3,857 | $4,546 | $4,062 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $19,929 | $20,245 | $19,242 | $19,242 |
| Retained Earnings | -$28,314 | -$28,072 | -$30,384 | -$29,808 |
| AOCI | $0 | $0 | $0 | $6,981 |
| Other Equity | $8,165 | $4,374 | $7,020 | $0 |
| Total Equity | -$220 | -$3,454 | -$4,121 | -$3,584 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,364 | $403 | $425 | $478 |
| Net Debt | -$687 | $1,153 | $1,711 | $1,690 |